Jul 1, 2021, 16:59 PM by

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), published its first annual sustainability report, consolidating the company’s policies for an enhanced ESG management system and related plans. The report focuses on the company’s commitment to taking part in social responsibility over the past decade and its future plans for the next ten years and beyond.

Jul 1, 2021, 16:59 PM by

Watson-Marlow Fluid Technology Group announces it has been named winner of the Best Employer category at the 2021 Best Business Awards.

Jul 1, 2021, 16:59 PM by

BRIM Biotechnology, Inc. is pleased to advise that the Type C meeting with the US Food and Drug Administration (FDA) for the further development of lead candidate BRM421 for Dry Eye Syndrome (DES) has taken place, and preparation to initiate Phase III trials in 2022, is underway.

Jul 1, 2021, 16:59 PM by

Lyniate announces that it has been selected by CyncHealth to support its explosive growth throughout the Midwest.

Jul 1, 2021, 16:59 PM by

Published in AI Letters, the study collaborators Optibrium, Takeda and Intellegens, demonstrated the application of deep learning imputation to a global pharma dataset, offering new insights into drug discovery data that transform how complex data can be used to identify opportunities for new drugs and streamline the drug discovery process.

Jul 1, 2021, 16:58 PM by

About Bio-Gate: Bio-Gate AG is one of the world’s leading providers of innovative technologies and customised solutions for health and hygiene. Our aim is to make living together safer and healthier and to improve the well-being of all individuals. Bio-Gate enhances materials and products with its technologies and antimicrobial and antiviral strategies, and, thereby improves the quality of life of people and animals alike. The company specializes in equipping materials and surfaces with antiviral and antimicrobial properties. Bio-Gate AG enhances materials and products, particularly in the field of medical technology, such as the coating of implants or wound dressings. In addition, Bio-Gate technologies are used to provide consumer, industrial and hygiene products, such as paints, coatings, plastics or protective film sprays with antiviral and antimicrobial properties, thus enhancing them in a unique way. Bio-Gate also uses its unique and multi-functional additive MicroSilver BG in dermatology and cosmetics as well as wound care to provide these kind of products with long-lasting antimicrobial, anti-inflammatory and Microbiome friendly properties.

Jul 1, 2021, 16:58 PM by

CluePoints, the premier provider of Risk-Based Quality Management Solutions for clinical trials, has launched a new Post-COVID Trial Assurance Solution as part of its mission to build safer, more efficient trials for patients, sponsors and CROs.

Jul 1, 2021, 16:58 PM by

Belgium-based AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with AdhereTech, an innovative company that improves the patient experience with real-time technology and Smart devices for optimal medication benefits.

Jul 1, 2021, 16:58 PM by

Stilla Technologies welcomes Dr. Matthew Grow on board as the company extends its global footprint in the digital PCR marketplace.

Jul 1, 2021, 16:58 PM by

Jul 1, 2021, 01:00 AM by User Not Found

Bio-IT World | Insilico Medicine closes a Series C for AI-powered drug discovery, while other investments fuel remote access labs, natural products, high throughput screening, and more.

Jun 30, 2021, 01:00 AM by User Not Found

Bio-IT World | In recent years, scientific research has moved from being process-driven to data-driven. Scientists are inferring the results of experiments by analyzing more data than ever, and it’s clear that companies that own the cleanest, best-annotated data will be the most successful in making ground-breaking discoveries within this paradigm. That said there are still significant challenges to data-driven research.

Jun 29, 2021, 03:33 AM by User Not Found

Bio-IT World | Colorado researchers publish a new method to increase the utility and equity of large genetic databases, new collaboration for BC Platforms and CareDuchenne, Minnesota Supercomputing Institute joins iRODS, and what’s next for Biogen and Eisai. Plus new products from Benchling, Egnyte, Cytek, Waters, Bruker, and more.

Jun 24, 2021, 01:00 AM by User Not Found

Bio-IT World | If there’s anything the global pandemic has taught healthcare providers, it is the importance of timely and accurate data analysis and being ready to act on it. Yet these same organizations must move within the bounds of patient rights regulations, both existing and emerging, making it harder to access the data needed for building relevant artificial intelligence (AI) models. One way to get around this constraint is de-identify the data before curating it into one centralized location where it can be used for AI model training.

Jun 23, 2021, 01:00 AM by User Not Found

Bio-IT World | Clinical trials employing digital representations of patients and running in parallel with actual clinical trials could soon help researchers understand what separates responders and nonresponders to a drug.

Jun 22, 2021, 01:00 AM by User Not Found

Bio-IT World | Lihua Yu took on the role of President of H3 three years ago; she oversees R&D and corporate development operations. She discusses her career trajectory and how the ideas and technologies fueling precision medicine have evolved since she joined H3.

Jun 21, 2021, 14:24 PM by

Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities.

Jun 21, 2021, 14:24 PM by

Torus Biosystems Announces $25 Million Series A Financing for syndromic testing solution designed for point-of-care use in ambulatory care settings such as hospital outpatient and emergency departments.

Jun 21, 2021, 14:22 PM by

A team of scientists led by James Godwin, Ph.D., of the MDI Biological Laboratory in Bar Harbor, Maine, has come a step closer to unraveling the mystery of why salamanders can regenerate while adult mammals cannot with the discovery of differences in molecular signaling that promote regeneration in the axolotl, a highly regenerative salamander, while blocking it in the adult mouse, a mammal like humans with limited regenerative ability. The discovery could open the door to pharmaceutical therapies that stimulate regeneration in tissues and organs lost to disease or injury.

Jun 21, 2021, 14:22 PM by

Cotiviti, a leading technology and analytics company, is honored for developing its COVID-19 Outbreak Tracker during the height of the pandemic to help forecast potentially hidden infection outbreaks.